DD143779A5 - Verfahren zur herstellung von 4''-desoxy-4''-oxo-erythromycin-a-derivaten - Google Patents

Verfahren zur herstellung von 4''-desoxy-4''-oxo-erythromycin-a-derivaten Download PDF

Info

Publication number
DD143779A5
DD143779A5 DD78213231A DD21323178A DD143779A5 DD 143779 A5 DD143779 A5 DD 143779A5 DD 78213231 A DD78213231 A DD 78213231A DD 21323178 A DD21323178 A DD 21323178A DD 143779 A5 DD143779 A5 DD 143779A5
Authority
DD
German Democratic Republic
Prior art keywords
erythromycin
oxo
deoxy
reaction
compounds
Prior art date
Application number
DD78213231A
Other languages
German (de)
English (en)
Inventor
Frank Ch Sciavolino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD143779A5 publication Critical patent/DD143779A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD78213231A 1977-02-04 1978-02-03 Verfahren zur herstellung von 4''-desoxy-4''-oxo-erythromycin-a-derivaten DD143779A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76548077A 1977-02-04 1977-02-04

Publications (1)

Publication Number Publication Date
DD143779A5 true DD143779A5 (de) 1980-09-10

Family

ID=25073668

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78213231A DD143779A5 (de) 1977-02-04 1978-02-03 Verfahren zur herstellung von 4''-desoxy-4''-oxo-erythromycin-a-derivaten

Country Status (10)

Country Link
US (1) US4150220A (fr)
JP (3) JPS5853000B2 (fr)
AT (1) AT359643B (fr)
BE (1) BE863621A (fr)
CS (2) CS221803B2 (fr)
DD (1) DD143779A5 (fr)
HU (1) HU184999B (fr)
PL (1) PL115793B1 (fr)
SU (3) SU837326A3 (fr)
ZA (1) ZA78676B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283527A (en) * 1980-04-01 1981-08-11 Pfizer Inc. Erythromycylamine 11,12-carbonate and derivatives thereof
US4413119A (en) * 1982-03-01 1983-11-01 Pfizer Inc. Semi-synthetic macrolides
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
US4363803A (en) * 1982-03-01 1982-12-14 Pfizer Inc. 3",4"-Oxyallylene erythromycin and oleandomycin, composition and method of use
US4382086A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A
DK149776C (da) * 1984-01-06 1987-04-21 Orion Yhtymae Oy Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4847242A (en) 1985-03-12 1989-07-11 Beecham Group P.L.C. 11-ether derivatives of erythromycins
US5175150A (en) * 1985-08-31 1992-12-29 Kitasato, Kenkyusho Erythromycin derivative
US4672056A (en) * 1985-11-12 1987-06-09 Abbott Laboratories Erythromycin A derivatives and method of use
FR2639945B1 (fr) * 1988-12-07 1994-03-25 Oreal Ethers et/ou esters lipophiles de d-desosamine, leur procede de preparation et leur utilisation en tant qu'agents antibacteriens et antifongiques
US5808017A (en) * 1996-04-10 1998-09-15 Abbott Laboratories Process for preparing erythromycin A oxime
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US3842069A (en) * 1973-06-21 1974-10-15 Abbott Lab 4"-deoxy-4"-oxoerythromycin b derivatives

Also Published As

Publication number Publication date
CS221803B2 (en) 1983-04-29
ATA75378A (de) 1980-04-15
ZA78676B (en) 1978-12-27
SU1172451A3 (ru) 1985-08-07
CS221802B2 (en) 1983-04-29
JPS57154199A (en) 1982-09-22
JPS5827800B2 (ja) 1983-06-11
SU886749A3 (ru) 1981-11-30
JPS57158799A (en) 1982-09-30
BE863621A (fr) 1978-08-03
PL115793B1 (en) 1981-04-30
JPS597718B2 (ja) 1984-02-20
AT359643B (de) 1980-11-25
JPS5853000B2 (ja) 1983-11-26
JPS57154198A (en) 1982-09-22
HU184999B (en) 1984-11-28
SU837326A3 (ru) 1981-06-07
US4150220A (en) 1979-04-17

Similar Documents

Publication Publication Date Title
DE60122791T2 (de) Verfahren zur Herstellung von Clarythromycin mit nicht pharmazeutischer Qualität
DE69818977T2 (de) 3'-n-oxid,3'-n-dimethylamin,9-oxime erythromycin a derivate
DD143779A5 (de) Verfahren zur herstellung von 4''-desoxy-4''-oxo-erythromycin-a-derivaten
DD216017A5 (de) Verfahren zur herstellung von 4"-epi-9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
DE69908338T2 (de) 15-gliedrige ketolid-lactame mit antibakterieller wirkung
EP0030295A1 (fr) Procédé de préparation de 4'-épidaunorubicine, 3',4'-diépidaunorubicine, produits intermédiaires et utilisation de ces derniers
DD211565A5 (de) Verfahren zur herstellung von 4"-epi-erythromycin a und derivaten hiervon als brauchbare antibakterielle mittel
DE2953969C2 (fr)
DE1917874B2 (de) 14-Halogendaunomycine, Verfahren zu ihrer Herstellung und deren Verwendung zur Herstellung von Adriamycin
DE2937267A1 (de) 3'',4''-diacyltylosinderivate
DE602004003054T2 (de) Neue 3-decladinosyl-9a-n-carbamoyl- und 9a-n-thiocarbamoylderivate von 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a
DE2740950A1 (de) Verfahren zur herstellung von flavonen
DE2804507C2 (de) 4"-Desoxy-4"-amino-erythromycin-A und dessen Derivate sowie diese Verbindungen enthaltende antibakterielle Mittel
CH615197A5 (en) Process for the preparation of antibiotic compounds
CH630391A5 (en) Process for preparing derivatives of rosaramicin
DE2804509C2 (de) 4"-Amino-oleandomycin-Derivate und diese Verbindungen enthaltende antibakterielle Mittel
DE60205377T2 (de) Verfahren zur arylierung von funktionalisierten o-allyl erythromycin derivaten
DE69935250T2 (de) Oleandomycin-derivate
CH661513A5 (de) 14-de-(hydroxymethyl)-mycaminosyltylonolid-verbindungen.
DE2900120C2 (fr)
EP0394907A1 (fr) Procédé pour la production d'étoposides
DE3886101T2 (de) 14-Chlorodaunomycin und Verfahren zur Herstellung von 14-Chlorodaunomycin und Verfahren zur Herstellung von (2"R)-4'-O-Tetrahydropyramyladriamycin.
AT361629B (de) Verfahren zur herstellung von neuen 4''- -erythromycin-a-derivaten
DE3009910C2 (de) 3',4'-Diepi-4'-O-methyl-daunorubicin und -doxorubicin, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE2856534A1 (de) 11-alkanoyl-4''desoxy-4''-isonitrilo-oleandomycin-derivate und ihre verwendung